AQUESTIVE THERAPEUTICS INC's ticker is AQST and the CUSIP is 03843E104. A total of 55 filers reported holding AQUESTIVE THERAPEUTICS INC in Q2 2023. The put-call ratio across all filers is 0.02 and the average weighting 1.8%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2024 | $88,400 | +3.8% | 34,000 | +70.0% | 0.01% | 0.0% |
Q1 2024 | $85,200 | +110.9% | 20,000 | 0.0% | 0.01% | +66.7% |
Q4 2023 | $40,400 | +32.0% | 20,000 | 0.0% | 0.00% | +50.0% |
Q3 2023 | $30,600 | -7.3% | 20,000 | 0.0% | 0.00% | 0.0% |
Q2 2023 | $33,000 | +15.8% | 20,000 | -20.0% | 0.00% | 0.0% |
Q1 2023 | $28,500 | -1.3% | 25,000 | -21.9% | 0.00% | 0.0% |
Q4 2022 | $28,867 | -9.8% | 32,000 | +18.5% | 0.00% | -33.3% |
Q3 2022 | $32,000 | +88.2% | 27,000 | 0.0% | 0.00% | +200.0% |
Q2 2022 | $17,000 | -66.7% | 27,000 | +38.5% | 0.00% | -66.7% |
Q1 2022 | $51,000 | -32.9% | 19,500 | 0.0% | 0.00% | -40.0% |
Q4 2021 | $76,000 | +2.7% | 19,500 | +14.7% | 0.01% | 0.0% |
Q3 2021 | $74,000 | +10.4% | 17,000 | 0.0% | 0.01% | +25.0% |
Q2 2021 | $67,000 | -1.5% | 17,000 | +30.8% | 0.00% | -20.0% |
Q1 2021 | $68,000 | -10.5% | 13,000 | -8.5% | 0.01% | 0.0% |
Q4 2020 | $76,000 | – | 14,200 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Bratton Capital Management, L.P. | 9,810,958 | $42,776,000 | 100.00% |
Latash Investments, LLC | 243,134 | $1,060,000 | 0.66% |
Bracebridge Capital, LLC | 428,571 | $1,869,000 | 0.16% |
GSA CAPITAL PARTNERS LLP | 297,229 | $1,296,000 | 0.13% |
PDT Partners, LLC | 76,100 | $332,000 | 0.02% |
Jump Financial, LLC | 49,700 | $216,000 | 0.02% |
BRIDGEWAY CAPITAL MANAGEMENT, LLC | 183,000 | $798,000 | 0.02% |
IndexIQ Advisors LLC | 86,461 | $377,000 | 0.01% |
Financial Advocates Investment Management | 17,000 | $74,000 | 0.01% |
Brandywine Global Investment Management, LLC | 125,016 | $545,000 | 0.00% |